2020 JSGE/JSH循证临床实践指南:肝硬化

2021-07-06 Hepatol Res. 2021 Jul 6.

2020年日本肝硬化指南是对2015年版指南的更新,肝硬化是慢性肝病晚期的表现,患者的肝功能从代偿期到失代偿期,会出现各种并发症,生活质量和预后明显降低。本文主要针对肝硬化的诊断和治疗提供循证指导建议

中文标题:

2020 JSGE/JSH循证临床实践指南:肝硬化

英文标题:

Evidence-based clinical practice guidelines for liver cirrhosis 2020

发布机构:

发布日期:

2021-07-06

简要介绍:

2020年日本肝硬化指南是对2015年版指南的更新,肝硬化是慢性肝病晚期的表现,患者的肝功能从代偿期到失代偿期,会出现各种并发症,生活质量和预后明显降低。本文主要针对肝硬化的诊断和治疗提供循证指导建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 JSGE_JSH循证临床实践指南:肝硬化.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c3f1b1c002133667, title=2020 JSGE/JSH循证临床实践指南:肝硬化, enTitle=Evidence-based clinical practice guidelines for liver cirrhosis 2020, guiderFrom=Hepatol Res. 2021 Jul 6., authorId=0, author=, summary=2020年日本肝硬化指南是对2015年版指南的更新,肝硬化是慢性肝病晚期的表现,患者的肝功能从代偿期到失代偿期,会出现各种并发症,生活质量和预后明显降低。本文主要针对肝硬化的诊断和治疗提供循证指导建议, cover=https://img.medsci.cn/2021722/1626958872662_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Jul 06 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年日本肝硬化指南是对2015年版指南的更新,肝硬化是慢性肝病晚期的表现,患者的肝功能从代偿期到失代偿期,会出现各种并发症,生活质量和预后明显降低。本文主要针对肝硬化的诊断和治疗提供循证指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=492, tagName=肝硬化)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=492, guiderKeyword=肝硬化, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10695, appHits=307, showAppHits=0, pcHits=1204, showPcHits=10386, likes=1, shares=24, comments=16, approvalStatus=1, publishedTime=Thu Jul 22 22:12:09 CST 2021, publishedTimeString=2021-07-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 22 21:01:25 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 01:10:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 JSGE_JSH循证临床实践指南:肝硬化.pdf)])
2020 JSGE_JSH循证临床实践指南:肝硬化.pdf
下载请点击:
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1233298, encodeId=8cdb1233298e9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 22:10:12 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196565, encodeId=72e1119656593, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=蔡远辉, createdTime=Wed Feb 23 21:35:14 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182109, encodeId=27dd118210920, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:50:52 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083490, encodeId=3bd71083490e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=acllmtFg9XqRGLxFEV9xUA&s=100&t=1564329227, createdBy=55e45151166, createdName=ms3342359274013302, createdTime=Thu Dec 23 10:29:35 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082692, encodeId=b9d61082692b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:38:10 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-07-18 ms5000000740006324

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1233298, encodeId=8cdb1233298e9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 22:10:12 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196565, encodeId=72e1119656593, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=蔡远辉, createdTime=Wed Feb 23 21:35:14 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182109, encodeId=27dd118210920, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:50:52 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083490, encodeId=3bd71083490e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=acllmtFg9XqRGLxFEV9xUA&s=100&t=1564329227, createdBy=55e45151166, createdName=ms3342359274013302, createdTime=Thu Dec 23 10:29:35 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082692, encodeId=b9d61082692b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:38:10 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-02-23 蔡远辉

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1233298, encodeId=8cdb1233298e9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 22:10:12 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196565, encodeId=72e1119656593, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=蔡远辉, createdTime=Wed Feb 23 21:35:14 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182109, encodeId=27dd118210920, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:50:52 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083490, encodeId=3bd71083490e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=acllmtFg9XqRGLxFEV9xUA&s=100&t=1564329227, createdBy=55e45151166, createdName=ms3342359274013302, createdTime=Thu Dec 23 10:29:35 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082692, encodeId=b9d61082692b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:38:10 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2022-01-08 ms2000001396659603

    厉害

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1233298, encodeId=8cdb1233298e9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 22:10:12 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196565, encodeId=72e1119656593, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=蔡远辉, createdTime=Wed Feb 23 21:35:14 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182109, encodeId=27dd118210920, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:50:52 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083490, encodeId=3bd71083490e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=acllmtFg9XqRGLxFEV9xUA&s=100&t=1564329227, createdBy=55e45151166, createdName=ms3342359274013302, createdTime=Thu Dec 23 10:29:35 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082692, encodeId=b9d61082692b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:38:10 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-23 ms3342359274013302

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1233298, encodeId=8cdb1233298e9, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b06d5649210, createdName=ms5000000740006324, createdTime=Mon Jul 18 22:10:12 CST 2022, time=2022-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196565, encodeId=72e1119656593, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/f6ec0ca6c7e849a18869167cd0e3c9b1/003cba24eefc40e094965ae4d343c573.jpg, createdBy=258d5150395, createdName=蔡远辉, createdTime=Wed Feb 23 21:35:14 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182109, encodeId=27dd118210920, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2656454425, createdName=ms2000001396659603, createdTime=Sat Jan 08 08:50:52 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083490, encodeId=3bd71083490e8, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=acllmtFg9XqRGLxFEV9xUA&s=100&t=1564329227, createdBy=55e45151166, createdName=ms3342359274013302, createdTime=Thu Dec 23 10:29:35 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082692, encodeId=b9d61082692b7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3eb25720983, createdName=ms5000001976519034, createdTime=Tue Dec 21 20:38:10 CST 2021, time=2021-12-21, status=1, ipAttribution=)]
    2021-12-21 ms5000001976519034

    不错

    0

拓展阅读

AASLD成人肝硬化腹水治疗指南2012年修订版

美国肝病研究学会(AASLD,American Association for the Study of Liver Diseases) · 2013-04-08

肝硬化门静脉高压食管胃静脉曲张出血的防治指南

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-06-02

2015年多学科专家共识:危重患者肝硬化的管理

美国移植学会(AST,American Society of Transplantation) · 2016-06-02

2016年AISF/SIMTI意见书:肝硬化患者合理使用白蛋白

意大利肝病学会(AISF,Italian Association for the Study of the Liver) · 2016-06-02

原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015)

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-06-02